Precision BioSciences Inc
NASDAQ:DTIL

Watchlist Manager
Precision BioSciences Inc Logo
Precision BioSciences Inc
NASDAQ:DTIL
Watchlist
Price: 12.405 USD 1.1% Market Closed
Updated: May 30, 2024

Precision BioSciences Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Precision BioSciences Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Precision BioSciences Inc
NASDAQ:DTIL
Revenue
$57.5m
CAGR 3-Years
20%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$54.4B
CAGR 3-Years
3%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.5B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Revenue
$29.5B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$10.2B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
26%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
13%
CAGR 5-Years
15%
CAGR 10-Years
19%

See Also

What is Precision BioSciences Inc's Revenue?
Revenue
57.5m USD

Based on the financial report for Mar 31, 2024, Precision BioSciences Inc's Revenue amounts to 57.5m USD.

What is Precision BioSciences Inc's Revenue growth rate?
Revenue CAGR 5Y
31%

Over the last year, the Revenue growth was 88%. The average annual Revenue growth rates for Precision BioSciences Inc have been 20% over the past three years , 31% over the past five years .